Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

PAN-study: Pan-Cancer Early Detection Study

NCT03756597 is registered in ClinicalTrials.gov with Owlstone Ltd as lead sponsor.

NCT NCT03756597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03756597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
PAN-study: Pan-Cancer Early Detection Study
Lead sponsor
Owlstone Ltd
Phase
Observational
Overall status
Completed
Start date
September 26, 2018
Completion date
July 6, 2023
Enrollment
268 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

esophageal cancer, gastric cancer, liver cancer